Literature DB >> 4986530

Hemostatic defects in dysproteinemias.

H A Perkins, M R MacKenzie, H H Fudenberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4986530

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  19 in total

Review 1.  Antibody-mediated tissue damage. Hyperviscosity and other complications of paraproteinaemia.

Authors:  F E Preston
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

2.  Waldenström's macroglobulinemia.

Authors:  C A Ries
Journal:  West J Med       Date:  1988-03

3.  Acquired hemophilia in a patient with myeloma.

Authors:  L S Loftus; W N Arnold
Journal:  West J Med       Date:  1994-02

4.  IgA pyroglobulinaemia in lymphoma.

Authors:  M Madden; T C Morris; D Hayes; C A Humphrey; J H Robertson
Journal:  J Clin Pathol       Date:  1983-09       Impact factor: 3.411

Review 5.  Hypercoagulability in the Nephrotic syndrome.

Authors:  K Andrassy; E Ritz; J Bommer
Journal:  Klin Wochenschr       Date:  1980-10-01

Review 6.  Hemostatic changes in patients with malignancy.

Authors:  G H Goldsmith
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

7.  Lupus anticoagulant-like activity observed in a dimeric lambda protein produced by myeloma cells.

Authors:  A Shinagawa; H Kojima; T Kobayashi; K Kawada; T Nagasawa
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

8.  Case report: Macroglobulinemia in a dog.

Authors:  E B Mejia; S Carman; J H Lumsden
Journal:  Can Vet J       Date:  1979-01       Impact factor: 1.008

9.  Circulating heparan sulfate proteoglycan anticoagulant from a patient with a plasma cell disorder.

Authors:  M S Khoory; M E Nesheim; E J Bowie; K G Mann
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

10.  A myeloma paraprotein with specificity for platelet glycoprotein IIIa in a patient with a fatal bleeding disorder.

Authors:  G DiMinno; F Coraggio; A M Cerbone; A M Capitanio; C Manzo; M Spina; P Scarpato; G M Dattoli; P L Mattioli; M Mancini
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.